Glucagon-like peptide-1 (GLP-1) receptor agonists (e.g., semaglutide in Ozempic and Wegovy) and the dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro, Zepbound) work by mimicking naturally occurring hormones that regulate blood glucose and appetite
Clinical studies have not led to FDA approval for any indication
Consider these factors: Benefits to discuss: Blood sugar control, weight loss, potential cardiovascular benefits, and possible cancer-protective effects
For OUD in particular, since fentanyl dramatically increases the rate of accidental fatal overdose compared to heroin, we need medical options that can be used much earlier in the course of an addiction
Athletic anti-doping testing Athletes subject to anti-doping regulations face an entirely different situation
The trade-off is bundle pricing thats more predictable up front and an offering that covers substantially more of the mens optimization stack than any GLP-1-only program